Type 2 Diabetes
Conditions
Brief summary
In Belgium, various structures and reimbursement programs are in place for managing Type 2 Diabetes Mellitus (T2DM). The Diabetes Care Trajectory is primarily utilized for patients who require a maximum of two insulin injections per day. In contrast, patients needing multiple daily insulin injections are managed under a diabetes convention program. The Diabetes Care Trajectory has been operational since 2009. However, unlike patients in the diabetes convention program, where the profile and quality of care are regularly audited, there is limited information available regarding the profile and outcomes of patients within the Care Trajectory. This retrospective study aims to compare the profiles, including complications and quality of care, of T2DM patients across both groups.
Detailed description
This retrospective study will collect data from T2DM patients enrolled in either the Diabetes Care Trajectory or the diabetes convention program. The data gathered will encompass quality of care, clinical status, complications, and metabolic state. The profiles of these patient populations will be compared cross-sectionally for each year within the study period (2009-2024). Additionally, a longitudinal analysis will be conducted to examine the evolution of these profiles over the entire study period. Data will be extracted from electronic case records maintained at participating sites across Belgium.
Interventions
OTHERFollow-up in the Diabetes Care Trajectory
Being followed-up in the Diabetes Care Trajectory in Belgium
OTHERFollow-up in the Diabetes Convention
Being followed-up in the Diabetes Convention in Belgium
Sponsors
Universitaire Ziekenhuizen KU Leuven
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Followed in one of the NexusHealth hospitals in Belgium: https://www.nexuzhealth.com/en/why-nexuzhealth/patients/affiliated-healthcare-institutions * Having being diagnosed with type 2 diabetes mellitus * Followed in the Diabetes Care Trajectory or in the Diabetes Convention (group B) in Belgium
Exclusion criteria
no specific
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HbA1c | Yearly for the entire study period (2009 - 2024) | Glycated haemoglobin A1c |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Complications of diabetes | Yearly for the entire study period (2009 - 2024) | Number of diabetes-associated complications such as retinopathy, nephropathy and macroangiopathy. |
| Cholesterol profile | Yearly for the entire study period (2009 - 2024) | Total levels of cholesterol |
| Insulin requirements | Yearly for the entire study period (2009 - 2024) | The need for insulin (units) on a daily basis |
Contacts
Primary ContactAstrid Lavens
Backup ContactLisa Van Ryckeghem, PhD
Outcome results
None listed